California Public Employees Retirement System’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-159,100
Closed -$280K – 1554
2021
Q1
$280K Hold
159,100
– – ﹤0.01% 3254
2020
Q4
$310K Sell
159,100
-3,300
-2% -$6.94K ﹤0.01% 3182
2020
Q3
$388K Sell
162,400
-7,933
-5% -$21.8K ﹤0.01% 2919
2020
Q2
$499K Buy
170,333
+82,150
+93% +$236K ﹤0.01% 2685
2020
Q1
$254K Hold
88,183
– – ﹤0.01% 2739
2019
Q4
$353K Buy
+88,183
New +$384K ﹤0.01% 2885

Other funds holding ADMA

California Public Employees Retirement System's ADMA Position: Q2 2021 in Review

California Public Employees Retirement System sold out of ADMA Biologics (ADMA) in Q2 2021, closing a stake of 159,100 shares — an estimated $280K sold.

California Public Employees Retirement System first reported a position in ADMA in Q4 2019 and held it in 6 quarters. The position peaked at $499K in Q2 2020. 90 funds tracked by Wall St. Rank hold ADMA as of Q2 2021.

  • California Public Employees Retirement System reported no remaining ADMA Biologics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 159,100 ADMA Biologics shares in Q2 2021, an estimated $280K.
  • California Public Employees Retirement System first reported a position in ADMA Biologics in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's ADMA Biologics position peaked at $499K in Q2 2020.
  • 90 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.